PharmaCyte Biotech Inc (PMCB)

[4Godnwv]

From a technical perspective, there are a lot of things wrong with the chart of NVLX – most indicators are turned south and the price is currently testing the 50dma – not good.
That said, the volume on this leg down is not what you’d expect to see - look back at the big down days in July, Aug, and Sept. – THAT is selling volume you want to see on a ‘Short’ – My guess is that sellers are drying up here, which means upside cometh! This needs to get above the 200dma (currently .275) to have legs.
For the record, I just own a few shares of this.